Farr Miller & Washington’s Evolent Health EVH Stock Holding History

Farr Miller & Washington’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.1M	Hold	100,000	–	–	0.2%	56
2021 Q2	$2.11M	Hold	100,000	–	–	0.14%	66
2021 Q1	$2.02M	Hold	100,000	–	–	0.14%	62
2020 Q4	$1.6M	Hold	100,000	–	–	0.12%	66
2020 Q3	$1.24M	Hold	100,000	–	–	0.11%	73
2020 Q2	$712K	Hold	100,000	–	–	0.06%	93
2020 Q1	$543K	Hold	100,000	–	–	0.05%	90
2019 Q4	$905K	Sell	100,000 -53,165	-35%	-$432K	0.07%	79
2019 Q3	$1.1M	Hold	153,165	–	–	0.09%	65
2019 Q2	$1.22M	Hold	153,165	–	–	0.1%	65
2019 Q1	$1.93M	Hold	153,165	–	–	0.16%	54
2018 Q4	$3.06M	Buy	+153,165	New	+$3.54M	0.29%	49

Other funds holding EVH

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Farr Miller & Washington's EVH Position: Q3 2021 in Review

Farr Miller & Washington held its Evolent Health (EVH) position steady in Q3 2021 at 100,000 shares worth $3.1M. The position accounts for 0.2% of the portfolio, ranked #56.

Farr Miller & Washington first reported a position in EVH in Q4 2018 and has held it in 12 quarters since. 209 funds tracked by Wall St. Rank hold EVH as of Q3 2021.

Farr Miller & Washington held 100,000 shares of Evolent Health worth $3.1M as of Q3 2021.
Farr Miller & Washington left its Evolent Health share count unchanged in Q3 2021.
Evolent Health made up 0.2% of Farr Miller & Washington's portfolio in Q3 2021, its #56 holding.
Farr Miller & Washington first reported a position in Evolent Health in Q4 2018 and has held it in 12 quarters since.
209 funds tracked by Wall St. Rank held Evolent Health as of Q3 2021.

Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.